Latest California Healthline Stories
FDA Ruling On Aussie Biotech Could Boost Congressman’s Investment
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
A esta madre hispana no le dijeron que tenía zika
Los resultados estuvieron listos en diciembre, pero Andrea Pardo no fue notificada hasta abril, cuando ya tenía 37 semanas de embarazo, de que había estado infectada con el virus del zika.
Asian-American Women Often Face Delays In Treatment After Worrisome Mammograms
A new study shows that a lower proportion of Asian women get timely follow-up appointments after abnormal mammograms than whites.
Clinic Mix-Up Underscores Questions About Zika Test Handling
The failure of a University of Washington clinic to inform a pregnant woman in a timely fashion that she had tested positive for Zika follows other reports of botched or delayed tests in the U.S. since the outbreak of the virus in 2015.
Un problema en aumento: los adultos mayores que quieren estar solos
Muchas veces por problemas de información, adultos mayores que son dados de alta rechazan la atención de salud en el hogar, decisión que los puede poner en riesgo.
As GOP Deliberates In Washington, Californians Fear For Their Health Coverage
A new survey shows more than half of Californians fear that they or a family member could lose coverage if Republican plans for the nation’s health care system become law.
Leaving Hospital, Older Patients Resist Home Help At Their Peril
Almost 30 percent of patients leaving the hospital don’t want home health care services, which often leads to readmissions and other health issues.
$20 Million On The Way For Clinics That Serve California’s Poor
The office of State Treasurer John Chiang said the money is an “emergency” response to federal health care cuts being proposed in Washington.
Ear To The Door: 5 Things Being Weighed In Secret Health Bill Also Weigh It Down
No one knows what the final Senate bill will look like — not even those writing it. But here are some safe, educated guesses.
Exclusive: White House Task Force Echoes Pharma Proposals
Documents examined by Kaiser Health News shed light on the workings of the Trump administration’s “Drug Pricing and Innovation Working Group.”